arrow
R

Rajiv Agarwal

Vanderbilt University
H指数:67
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis

在有无癌症病史的心肾代谢综合征患者中非奈利酮的获益:FINE-HEART合并分析

2026-08-180
OAAI
Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease-Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis-Stimulating Agent Dose

维达环素(vadadustat)与达贝泊汀α(darbepoetin alfa)治疗接受透析的慢性肾病相关贫血的疗效与安全性:基于基线促红细胞生成剂剂量的比较研究

2025-12-010
OAAI
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes

Finerenone在心力衰竭和伴有2型糖尿病的慢性肾脏病中心血管和肾脏获益的时间点

JACC
IF0
2025-11-180
OAAI
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials

人体测量指标、心血管结局及非奈利酮在心血管-肾脏-代谢疾病中的治疗效果:三项全球试验的合并受试者水平分析

JACC
IF0
2025-08-270
OAAI
S2303: phase II/III trial of paclitaxel plus ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

S2303: 紫杉醇联合雷莫芦单抗 ± nivolumab治疗胃和食管腺癌 (PARAMUNE) 的II/III期试验

2025-03-010
OAAI
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease

非奈利酮在2型糖尿病中的有效性与安全性:心力衰竭和慢性肾脏病临床试验的合并分析

2025-02-280
PRE
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes ( Sept , 10.1038/s41591-024-03264-4, 2024)
2024-10-280
OAAI
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis

2型糖尿病和慢性肾脏病患者的低钾血症: finerenone的影响-保真度分析

2024-10-081
OAAI
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes
2024-09-017
OAAI
Accuracy and Reliability of Chatbot Responses to Physician Questions

聊天机器人回答医生问题的准确性和可靠性

2023-10-0292
OAAI